Johnson & Johnson global trial finds Covid-19 vaccine is 66% effective
Dnia irlandzki portal thejournal.ie opublikował artykuł
pod tytułem: "Johnson & Johnson global trial finds Covid-19 vaccine is 66% effective",
w którym piszą, że
"JOHNSON & JOHNSON HAS announced that its single-dose vaccine was 72% effective in preventing Covid-19 in the United States but a lower rate of 66% was observed globally. The results came in a large...".
Zachęcamy do przeczytania wiadomości na stronie portalu thejournal.ie.